MENU
VNRX
AS OF
Feb 4, 11:07 AM (EDT)
Price
$0.26
Change
-$0.01 (-3.70%)
Capitalization
33.44M
55 days until earnings call
Intraday BUY SELL Signals
+Compare
VNRX
Stock ticker: ASE
AS OF
Feb 4, 11:07 AM (EDT)
Price
$0.26
Change
-$0.01 (-3.70%)
Capitalization
33.44M

VNRX VolitionRX Limited Forecast, Technical & Fundamental Analysis

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19... Show more

VNRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for VNRX with price predictions
Feb 03, 2026

VNRX's Stochastic Oscillator is staying in oversold zone for 9 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VNRX advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for VNRX moved out of overbought territory on January 09, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VNRX as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VNRX turned negative on January 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

VNRX moved below its 50-day moving average on January 21, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VNRX crossed bearishly below the 50-day moving average on January 27, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VNRX broke above its upper Bollinger Band on January 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VNRX entered a downward trend on January 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (11.546). P/E Ratio (0.000) is within average values for comparable stocks, (38.420). VNRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.636). VNRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (18.484) is also within normal values, averaging (38.937).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VNRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
VNRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

VNRX is expected to report earnings to fall 6.60% to -4 cents per share on March 31

VolitionRX Limited VNRX Stock Earnings Reports
Q4'25
Est.
$-0.05
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.02
Q4'24
Est.
$-0.05
The last earnings report on November 13 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 1.84M shares outstanding, the current market capitalization sits at 33.44M.
A.I. Advisor
published General Information

General Information

a development stage life sciences company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
1489 West Warm Springs Road
Phone
+1 646 650-1351
Employees
110
Web
https://www.volition.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASPN3.350.10
+3.08%
Aspen Aerogels
CSWC23.280.13
+0.56%
Capital Southwest Corp
THG174.05-0.45
-0.26%
Hanover Insurance Group (The)
BBVA25.65-0.28
-1.08%
Banco Bilbao Vizcaya Argentaria SA
BZFD0.86-0.03
-3.87%
BuzzFeed Inc.

VNRX and Stocks

Correlation & Price change

A.I.dvisor tells us that VNRX and TLSI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VNRX and TLSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNRX
1D Price
Change %
VNRX100%
-7.19%
TLSI - VNRX
29%
Poorly correlated
+2.82%
STRRP - VNRX
27%
Poorly correlated
-1.55%
SRDX - VNRX
25%
Poorly correlated
N/A
VAPO - VNRX
25%
Poorly correlated
N/A
IMDX - VNRX
24%
Poorly correlated
+5.21%
More

Groups containing VNRX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNRX
1D Price
Change %
VNRX100%
-7.19%
Medical/Nursing Services
industry (216 stocks)
3%
Poorly correlated
-0.81%
Health Services
industry (410 stocks)
1%
Poorly correlated
-0.91%